Latest Insider Transactions at Catalyst Pharmaceuticals, Inc. (CPRX)
This section provides a real-time view of insider transactions for Catalyst Pharmaceuticals, Inc. (CPRX). The data is sourced from Form 4 filings with the SEC, which are filed by insiders of CATALYST PHARMACEUTICALS, INC. to disclose their transactions in the company's securities. By reviewing this information, investors can gain insights into the trading activity of CATALYST PHARMACEUTICALS, INC.'s insiders and make more informed investment decisions.
Insider Transaction List
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Dec 12
2025
|
Molly Harper Director |
SELL
Open market or private sale
|
Direct |
26,746
-53.46%
|
$615,158
$23.33 P/Share
|
|
Dec 12
2025
|
Molly Harper Director |
BUY
Exercise of conversion of derivative security
|
Direct |
20,000
+40.73%
|
$100,000
$5.78 P/Share
|
|
Dec 08
2025
|
Donald A Denkhaus Director |
BUY
Exercise of conversion of derivative security
|
Direct |
1,413
+0.28%
|
-
|
|
Dec 08
2025
|
Preethi Sundaram Chief Strategy Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
1,669
-3.2%
|
-
|
|
Dec 08
2025
|
Preethi Sundaram Chief Strategy Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
6,855
+11.61%
|
-
|
|
Dec 08
2025
|
Patrick J Mcenany Director |
BUY
Exercise of conversion of derivative security
|
Direct |
3,534
+0.09%
|
-
|
|
Dec 08
2025
|
Molly Harper Director |
BUY
Exercise of conversion of derivative security
|
Direct |
1,413
+13.43%
|
-
|
|
Dec 08
2025
|
Jeffrey Del Carmen Chief Commercial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
2,492
-20.76%
|
-
|
|
Dec 08
2025
|
Jeffrey Del Carmen Chief Commercial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
8,039
+40.11%
|
-
|
|
Dec 08
2025
|
Tamar Thompson Director |
BUY
Exercise of conversion of derivative security
|
Direct |
1,413
+27.25%
|
-
|
|
Dec 08
2025
|
David S Tierney Director |
BUY
Exercise of conversion of derivative security
|
Direct |
1,413
+0.37%
|
-
|
|
Dec 08
2025
|
Steve Miller Chief Op. & Scientific Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
11,873
+1.09%
|
-
|
|
Dec 08
2025
|
Brian Elsbernd Chief Compliance/Legal Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
2,780
-1.15%
|
-
|
|
Dec 08
2025
|
Brian Elsbernd Chief Compliance/Legal Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
7,067
+2.85%
|
-
|
|
Dec 01
2025
|
Patrick J Mcenany Director |
SELL
Bona fide gift
|
Direct |
135,000
-1.05%
|
-
|
|
Nov 26
2025
|
Jeffrey Del Carmen Chief Commercial Officer |
SELL
Open market or private sale
|
Direct |
10,983
-73.49%
|
$252,609
$23.33 P/Share
|
|
Nov 26
2025
|
Jeffrey Del Carmen Chief Commercial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
10,983
+42.36%
|
$43,932
$4.21 P/Share
|
|
Nov 21
2025
|
Jeffrey Del Carmen Chief Commercial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
1,641
-29.29%
|
-
|
|
Nov 21
2025
|
Jeffrey Del Carmen Chief Commercial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
5,603
+50.0%
|
-
|
|
Nov 21
2025
|
Brian Elsbernd Chief Compliance/Legal Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
2,030
-0.86%
|
-
|
|
Nov 21
2025
|
Brian Elsbernd Chief Compliance/Legal Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
5,161
+2.14%
|
-
|
|
Nov 21
2025
|
Donald A Denkhaus Director |
BUY
Exercise of conversion of derivative security
|
Direct |
947
+0.19%
|
-
|
|
Nov 21
2025
|
Richard J Daly President and CEO |
SELL
Payment of exercise price or tax liability
|
Direct |
7,872
-3.19%
|
-
|
|
Nov 21
2025
|
Richard J Daly President and CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
20,006
+7.5%
|
-
|
|
Nov 21
2025
|
Molly Harper Director |
BUY
Exercise of conversion of derivative security
|
Direct |
947
+10.96%
|
-
|
|
Nov 21
2025
|
Patrick J Mcenany Director |
BUY
Exercise of conversion of derivative security
|
Direct |
1,775
+0.04%
|
-
|
|
Nov 21
2025
|
David S Tierney Director |
BUY
Exercise of conversion of derivative security
|
Direct |
947
+0.25%
|
-
|
|
Nov 21
2025
|
Michael Wayne Kalb Executive Vice President & CFO |
SELL
Payment of exercise price or tax liability
|
Direct |
2,485
-22.41%
|
-
|
|
Nov 21
2025
|
Michael Wayne Kalb Executive Vice President & CFO |
BUY
Exercise of conversion of derivative security
|
Direct |
6,894
+38.33%
|
-
|
|
Nov 21
2025
|
Tamar Thompson Director |
BUY
Exercise of conversion of derivative security
|
Direct |
947
+28.64%
|
-
|
|
Nov 21
2025
|
Steve Miller Chief Op. & Scientific Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
8,267
+0.77%
|
-
|
|
Nov 21
2025
|
Preethi Sundaram Chief Strategy Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
1,364
-2.92%
|
-
|
|
Nov 21
2025
|
Preethi Sundaram Chief Strategy Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
5,603
+10.72%
|
-
|
|
Nov 12
2025
|
Brian Elsbernd Chief Compliance/Legal Officer |
BUY
Open market or private sale
|
Direct |
40,000
+14.76%
|
$880,000
$22.7 P/Share
|
|
Sep 08
2025
|
Brian Elsbernd Chief Compliance/Legal Officer |
SELL
Open market or private sale
|
Direct |
30,000
-9.97%
|
$600,000
$20.3 P/Share
|
|
Sep 08
2025
|
Brian Elsbernd Chief Compliance/Legal Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
112,475
+27.2%
|
$224,950
$2.24 P/Share
|
|
Sep 04
2025
|
Brian Elsbernd Chief Compliance/Legal Officer |
SELL
Open market or private sale
|
Direct |
30,000
-13.73%
|
$570,000
$19.52 P/Share
|
|
Sep 04
2025
|
Brian Elsbernd Chief Compliance/Legal Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
30,000
+12.07%
|
$60,000
$2.24 P/Share
|
|
Sep 03
2025
|
Brian Elsbernd Chief Compliance/Legal Officer |
SELL
Open market or private sale
|
Direct |
20,000
-9.59%
|
$400,000
$20.08 P/Share
|
|
Sep 03
2025
|
Brian Elsbernd Chief Compliance/Legal Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
20,000
+8.75%
|
$40,000
$2.24 P/Share
|
|
Aug 27
2025
|
Steve Miller Chief Op. & Scientific Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
110,000
+9.4%
|
$220,000
$2.24 P/Share
|
|
Aug 27
2025
|
David S Tierney Director |
SELL
Open market or private sale
|
Direct |
26,000
-6.41%
|
$520,000
$20.2 P/Share
|
|
Aug 27
2025
|
David S Tierney Director |
BUY
Exercise of conversion of derivative security
|
Direct |
50,000
+10.97%
|
$100,000
$2.24 P/Share
|
|
Aug 26
2025
|
Richard J Daly President and CEO |
SELL
Open market or private sale
|
Direct |
22,970
-9.2%
|
$459,400
$20.62 P/Share
|
|
Aug 26
2025
|
Richard J Daly President and CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
50,000
+16.68%
|
$100,000
$2.24 P/Share
|
|
Aug 26
2025
|
Steve Miller Chief Op. & Scientific Officer |
SELL
Open market or private sale
|
Direct |
115,000
-10.8%
|
$2,300,000
$20.28 P/Share
|
|
Aug 26
2025
|
Steve Miller Chief Op. & Scientific Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
115,000
+9.75%
|
$230,000
$2.24 P/Share
|
|
Jun 11
2025
|
Preethi Sundaram Chief Strategy Officer |
SELL
Open market or private sale
|
Direct |
1,600
-3.75%
|
$41,600
$26.42 P/Share
|
|
Jun 10
2025
|
Preethi Sundaram Chief Strategy Officer |
SELL
Open market or private sale
|
Direct |
2,324
-5.16%
|
$60,424
$26.41 P/Share
|
|
Jun 09
2025
|
Patrick J Mcenany Director |
SELL
Open market or private sale
|
Direct |
171,748
-3.86%
|
$4,465,448
$26.11 P/Share
|